With 12,000 new cases diagnosed annually in France, kidney cancer ranks as the third most common urological tumour in adults. In recent years, minimally invasive kidney-sparing surgery using robotic assistance has become the preferred treatment approach.
The ACCURATE study aims to further improve the quality of surgical procedures by guiding the surgeon with advanced 3D modelling.
To date, 694 patients have been included in this study.
+ 7 new patients in March 2026.
The inclusion target has been met: the study is now complete!
A big thank you to all the centres and professionals involved in this great success. 